SMTL ID : 7bts.1

Structure of human beta1 adrenergic receptor bound to epinephrine and nanobody 6B9

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 3.13 Å

Oligo State

hetero-1-1-mer

Ligands

1 x ALE: L-EPINEPHRINE(Non-covalent)

ALE.1: 11 residues within 4Å: Chain A: D.255, V.256, V.259, F.335, S.345, S.349, F.403, F.404, N.407, N.426, Y.430 11 PLIP interactions: 11 interactions with chain A Hydrophobic interactions: A:V.256, A:V.256, A:V.259, A:F.335, A:F.403 Hydrogen bonds: A:S.345, A:S.345, A:S.349, A:N.407, A:N.426 pi-Stacking: A:F.404

6 x SO4: SULFATE ION(Non-functional Binders)

SO4.2: 6 residues within 4Å: Chain A: G.120, F.121, T.122, N.123, S.124, N.139 4 PLIP interactions: 4 interactions with chain A Hydrogen bonds: A:N.123, A:N.123, A:S.124, A:N.139 SO4.3: 3 residues within 4Å: Chain A: K.384, R.442, R.447 3 PLIP interactions: 3 interactions with chain A Salt bridges: A:K.384, A:R.442, A:R.447 SO4.4: 5 residues within 4Å: Chain A: T.149, P.150, N.151, R.152 Ligands: EPE.9 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:N.151, A:N.151, A:R.152 SO4.5: 3 residues within 4Å: Chain A: A.80, R.83, R.87 2 PLIP interactions: 2 interactions with chain A Salt bridges: A:R.83, A:R.87 SO4.6: 2 residues within 4Å: Chain A: R.126, R.132 2 PLIP interactions: 2 interactions with chain A Salt bridges: A:R.126, A:R.132 SO4.7: 4 residues within 4Å: Chain A: A.318, E.319, N.338, R.339 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:E.319, A:R.339 Salt bridges: A:R.339

1 x NA: SODIUM ION(Non-functional Binders)

NA.8: 4 residues within 4Å: Chain A: C.326, Y.327, D.329, C.332 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:C.326

1 x EPE: 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID(Non-functional Binders)

EPE.9: 9 residues within 4Å: Chain A: I.16, R.155, S.171, W.174, V.237, W.238, G.239, R.240 Ligands: SO4.4 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:R.155

1 x CLR: CHOLESTEROL(Non-covalent)

CLR.10: 4 residues within 4Å: Chain A: Y.351, V.409, F.412, H.413 3 PLIP interactions: 3 interactions with chain A Hydrophobic interactions: A:Y.351, A:V.409, A:F.412

1 x 1WV: (2S)-2,3-dihydroxypropyl (7Z)-tetradec-7-enoate(Non-covalent)

1WV.11: 6 residues within 4Å: Chain A: I.185, V.236, R.420, V.423, F.424, W.427 3 PLIP interactions: 3 interactions with chain A Hydrophobic interactions: A:I.185, A:F.424, A:W.427

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Xu, X. et al., Binding pathway determines norepinephrine selectivity for the human beta 1 AR over beta 2 AR. Cell Res. (2021)

Release Date

2020-12-02

Peptides

Lysozyme-Beta-1 adrenergic receptor chimera: A
Camelid Antibody Fragment: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

Membrane

We predict this structure to be a membrane protein.
Show / Hide

Lysozyme-Beta-1 adrenergic receptor chimera

Camelid Antibody Fragment

Related Entries With Identical Sequence